Abstract
Purpose To compare retinal oxygen delivery (DO2) and extraction (VO2) in ophthalmologically healthy subjects with different blood pressure (BP) status.
Methods In this case-control study, we prospectively included 93 eyes of 93 subjects (age 50-65) from a large-scale population-based Dutch cohort (n=167,000) and allocated them to four groups (low BP, normal BP [controls], treated arterial hypertension [AHT], untreated AHT). We estimated vascular calibers from fundus images and fractal dimension (FD) from optical coherence tomography angiography scans. We combined calibers, FD, BP, and intraocular pressure measurements in a proxy of total retinal blood flow (RBF), using a validated Poiseuille-based model. We measured arterial and venous oxygen saturations (SaO2, SvO2) with a two-wavelength scanning laser ophthalmoscope. We calculated DO2 and VO2 from RBF, SaO2, and SvO2. We compared DO2 and VO2 between groups and investigated the DO2-VO2 association.
Results DO2 and VO2 were different between groups (P=0.009, P=0.036, respectively). In post hoc analysis, the low BP group had lower DO2 than the untreated AHT group (P=4.9·10-4), while both the low BP group and the treated AHT group had lower VO2 than the untreated AHT group (P=0.021, P=0.034, respectively). There was a significant DO2-VO2 correlation (Robs=0.65, bobs=0.51, P=2.4·10-12). After correcting for shared measurement error, the slope was no longer significant (bcor=0.19, P=0.29), while the correlation coefficient could not be calculated.
Conclusions DO2 and VO2 were altered in ophthalmologically healthy subjects with different BP status. Future studies could elucidate whether these changes can explain the increased risk of several ophthalmic pathologies in those subjects.
Competing Interest Statement
The authors have declared no competing interest.
Clinical Trial
NL61508.042.17
Funding Statement
European Union's Horizon 2020 Innovative Training Networks Program, under the Marie Sklodowska-Curie grant, Project ID 675033. The funding organization had no role in the design, conduct, analysis, or publication of this research.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The ethics board of the University Medical Center Groningen approved the study protocol.
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
E-mail co-authors: n.m.jansonius{at}umcg.nl
Commercial relationships: No conflicting relationships exist for any author.
Financial support: European Union’s Horizon 2020 Innovative Training Networks Program, under the Marie Sklodowska – Curie grant, Project ID 675033. The funding organization had no role in the design, conduct, analysis, or publication of this research.
Meeting presentation: European Association for Vision and Eye Research (EVER); Nice, 3rd-6th October 2018
Data Availability
All data is available upon reasonable request to the corresponding author.
